New Content  edit
Get The App!

Free, Certified, On-Demand Lectures

IMPACT Live offers a series of breakfast/dinner grand rounds, visiting professorships and virtual lectures led by renowned faculty. Content is focused on hot topics in specific disease areas and novel approaches to achieving better outcomes for patients.

Certified events use outcomes-based, mobile-friendly platform to create a closed-loop learning experience, with pre-work programs and post-work quizzes to ensure lecture attendees retain concepts taught.

Free, Certified, On-Demand Lectures

IMPACT Live offers a series of breakfast/dinner grand rounds, visiting professorships and virtual lectures led by renowned faculty. Content is focused on hot topics in specific disease areas and novel approaches to achieving better outcomes for patients.

Certified events utilize our outcomes-based, mobile learning platform to create a closed-loop learning experience by providing pre-work programs and post-work quizzes to ensure attendees of the lectures retain concepts taught.

Program Overview

Pulmonary arterial hypertension (PAH) is a complex disease with multiple etiologies. The IMPACT PH program was established to provide physicians and allied health professionals with up-to-date information on this disease in order to facilitate patient identification, establish an effective diagnosis and to understand the risks and benefits of the various treatments now available.

The learning modules in this program cover a range of topics, from the more general aspects of PAH to specific situations, such as pulmonary hypertension associated with connective tissue diseases, like scleroderma. The programs use a case-based approach so that health professionals can follow the diagnostic pathway, using the appropriate tools, to finally arrive at the PAH diagnosis and determine the appropriate treatment.

Target Audience

These activities have been designed to meet the educational needs of physicians, registered nurses, and other healthcare professionals involved in the care of patients with pulmonary hypertension.


CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.

Available Topics

Modern Diagnostic Approaches in PAH

Learning Objectives
  • Discuss the recent revision of the hemodynamic definition of PAH by the World Symposium on Pulmonary Hypertension and how this new definition impacts identification of pre-capillary hypertension patients
  • Review how the new hemodynamic definition of pulmonary hypertension has impacted on the classification of PH
  • Debate the 2018 WSPH revision of the PH diagnostic algorithms as they are influenced by the new hemodynamic definition of PH
  • Employ the 2018 WSPH recommendations on screening for PAH, particularly in high risk groups

How Sick is my Patient? Practical Application of Risk Assessment Protocols to Optimize PAH Patient Care

Learning Objectives
  • Discuss integration of aggressive treatment goals into practice patterns
  • Employ the 2018 WHO proceedings recommendations in regard to treatment escalation and monitoring
  • Examine essential clinical data supporting aggressive combination therapy of PH to reduce risk of morbidity and mortality
  • Discuss risk-based treatment of PH and the goals of treatment based on current guidelines

Enhancing the patient experience in PAH- Modern approaches to patient treatment and improved Quality of Life

Learning Objectives
  • Discuss ways to improve identification of PAH patients and create effective treatment plans, incorporating risk stratification
  • Review recent trials of new therapies with morbidity/mortality endpoints and identify best practices on how to communicate these findings to patients
  • Identify opportunities for healthcare providers to better communicate and educate patients regarding therapy considerations
  • Utilize and discuss tools for health care providers to aid in improved QOL, including medication adherence and side effect management

The Future of PAH – Emerging Trials, Therapies, Devices and Treatment

Learning Objectives
  • Apply investigator-presented data to clinical practice, to expand treatment options and improve outcomes for patients
  • Discuss updated treatment guidelines and strategies
  • Adapt revised treatment guidelines into everyday practice in treating PAH
  • Assess new directions in medical therapy and new technologies to treat PAH
  • Review updates from studies of new drugs, devices and treatment modalities for treating PAH

PAH in the Rheumatology office- Identification and Treatment

Learning Objectives
  • Review the characteristics, definitions and pathophysiology of PAH as they relate to connective tissue disease
  • Discuss the procedures and merits of risk assessment for PAH in patients with connective tissue diseases
  • Consider diagnostic protocols for PAH in the CTD patient and the importance of partnering the rheumatologist with PH specialty centers for both diagnosis and treatment
  • Differentiate between PAH, PAH due to IPF and PH due to left heart disease
  • Evaluate the available treatments for the CTD-PAH patient in light of pivotal clinical trial data

Accreditation Information

Physician Continuing Medical Education

Accreditation Statement
These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Total CME. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
1.0 contact hour may be earned for successful completion of each activity.

California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 1.0 contact hour.

Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Fee Information
There is no fee for these educational activities.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within three weeks.

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Total CME in collaboration with Postgraduate Institute for Medicine

These activities are supported by an independent educational grant from Actelion Pharmaceuticals US, Inc.

Available Formats

At this time, all IMPACT Live events are available as a webinar. Please check the scheduled lectures tab to register for upcoming events.

Compliance with Sunshine Act

The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT PH programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit

IMPACT PH Steering Committee

Program Chair:

Vallerie McLaughlin, MD
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Associate Chief of Cardiovascular Medicine
Dept. of Internal Medicine/ Cardiovascular Medicine
University of Michigan
Ann Arbor, MI

Richard Channick, MD
Director, Acute and Chronic Thromboembolic Disease Program
Ronald Reagan UCLA Medical Center
Los Angeles, CA

Jean Elwing, MD
Professor, Department of Internal Medicine
Director, Pulmonary Hypertension Program
University of Cincinnati College of Medicine
Cincinnati, OH

Paul Forfia, MD, MS
Professor of Medicine
Director, Pulmonary Hypertension/Right Heart Failure and Pulmonary Thromboendarterectomy Program
Temple University
Philadelphia, PA

Martha Kingman Liberty, FNP-C, DNP
Nurse Practitioner, Pulmonary Services
Heart and Lung Center
UT Southwestern Medical Center
Dallas, TX

Richard Krasuski, MD, FACC, FAHA, FESC 
Professor of Medicine and Pediatrics
Director, Adult Congenital Heart Disease Center
Director of Hemodynamic Research
Duke University Medical Center
Durham, NC

Ioana Preston, MD
Associate Professor of Medicine
Director, Pulmonary Hypertension Center
Director, Pulmonary Function Test Lab
Tufts Medical Center
Boston, MA

Rajan Saggar, MD
Associate Professor of Medicine
Director, Medical Intensive Care Unit
Lung & Heart-Lung Transplant
and PH Program
David Geffen School of Medicine
UCLA Medical Center
Los Angeles, CA

Sean Studer, MD, MSc, FCCP
Associate Professor of Medicine
SUNY Downstate Medical School
Chief of Medicine
NYC Health + Hospitals/Kings County
New York, NY

Victor Tapson, MD
Professor of Medicine
Division of Pulmonary and Critical Care
Cedars-Sinai Medical Center
Los Angeles, CA


Raymond L. Benza, MD
Allegheny General Hospital
Pittsburgh, PA

Charles Burger, MD
Mayo Clinic
Jacksonville, FL

Murali Chakinala, MD
Washington University School of Medicine
St. Louis, MO

Curt Daniels, MD
The Ohio State University 
Werner Medical Center
Columbus, OH

Theresa De Marco, MD
University of California San Francisco
San Francisco, CA

Harrison Farber, MD
Tufts University
Boston, MA

Patricia George, MD
National Jewish Health
Denver, CO

Nicholas Hill, MD
Tufts University School of Medicine
Boston, MA

Wendy Hill, MSN, NP-C
Cedar-Sinai Medical Center
Los Angeles, California

Dinesh Khanna, MD, MSc
University of Michigan Medical Center
Ann Arbor, MI

Nick H. Kim, MD
UC San Diego Health
La Jolla, CA

Sandra Lombardi, RN
University of California, San Diego
School of Medicine
La Jolla, CA

Stephen Mathai, MD, MHS
Johns Hopkins University School of Medicine
Baltimore, MD

John McConnell, MD
Kentuckiana Pulmonary Associates
Louisville, KY

Susie McDevitt, RN, MSN, ACNP-BC
University of Michigan
Ann Arbor, MI

Omar Minai, MD
Liberty University COM
Southside Regional Medical Center
Petersburg, VA

Ronald Oudiz, MD, FACP, FACC, FCCP
Harbor-UCLA Medical Center
Torrance, CA

Harold Palevsky, MD
Perelman School of Medicine of the
University of Pennsylvania
Philadelphia, PA

Franck Rahaghi, MD, MHS, FCCP
Cleveland Clinic
Weston, FL

Zeenat Safdar, MD
Houston Methodist Hospital,
 Weill Cornell College of Medicine
Houston, TX

Jeffrey Sager, MD, MS
Santa Barbara Pulmonary Consultants
Santa Barbara, CA

Robert Schilz, DO, PhD
Case Western Reserve University
School of Medicine
Cleveland, OH

Traci Stewart, RN, MSN, CHFN
University of Iowa
Iowa City, Iowa

Sean Studer, MD, MSc
NYC Health + Hospitals/Kings County
Brooklyn, NY

Roxana Sulica, MD
NYU Langone Health
New York, NY

Victor Test, MD
Texas Tech University Medical School
Lubbock, TX

Fernando Torres, MD
University of Texas Southwestern
Medical Center
Dallas, TX

Anjali Vaidya, MD
Temple University Lewis Katz School of Medicine
Philadelphia, PA

Melisa Wilson, ARNP
Advent Health
Orlando, FL